Clinical Sequencing

Researchers used NGS to profile the tumors of metastatic colorectal carcinoma patients enrolled in the CAPRI-GOIM clinical trial.

The company is embarking on a study of up to 2,000 patients to compare its tissue-based targeted sequencing assay with its cell-free DNA test.

Researchers have created panels for ovarian hyperstimulation syndrome and to detect mutations in BCR-ABL1 gene fusions.

Diagnostic sequencing will be done on the Illumina HiSeq X Ten, the HiSeq 2500, and the NextSeq 500 in HudsonAlpha's CLIA-certified Genomics Services Laboratory.

The privately-held German firm also plans to offer genetic tumor profiling and noninvasive prenatal testing.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.